Motion sickness in migraine sufferers

Author： Marcus Dawn A   Furman Joseph M   Balaban Carey D  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.15, 2005-12, pp. : 2691-2697

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prodigy gives migraine sufferers a headache

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 274, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Prevention and Treatment of Motion Sickness in Children

By Gordon C.R.  

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 369-381

Adis International

Access to resources Recommend Favorite

Prophylactic effect of serotonin uptake inhibitors against motion sickness in Suncus murinus

By Okada F.   Saito H.   Matsuki N.  

European Journal of Pharmacology, Vol. 309, Iss. 1, 1996-08 ,pp. : 33-35

Elsevier

Access to resources Recommend Favorite

Scopolamine Sublingual Spray: An Alternative Route of Delivery for the Treatment of Motion Sickness

By Al-Ghananeem Abeer M.   Malkawi Ahmad H.   Crooks Peter A.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 5, 2007-05 ,pp. : 577-582

Informa Healthcare

Access to resources Recommend Favorite

Transdermal Scopolamine for Prevention of Motion Sickness: Clinical Pharmacokinetics and Therapeutic Applications

By Nachum Zohar   Shupak Avi   Gordon Carlos R.  

Clinical Pharmacokinetics, Vol. 45, Iss. 6, 2006-01 ,pp. : 543-566

Adis International

Access to resources Recommend Favorite